Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

IMERYS To Acquire AMCOL Int'l. For $1.6 Bln, Incl. Debt - Quick Facts

AMCOL International Corp. (ACO: Quote) has reached a definitive merger deal with Imerys S.A., under which AMCOL shareholders would receive $41 per share cash for each AMCOL common share that they own, without interest. The $41 per share consideration represents nearly 19% premium to the volume weighted average closing price of the company's common stock over the last 30 trading days through February 11, 2014. The transaction, worth around $1.6 billion, including AMCOL's debt, represents around 10.3x 2013 EBITDA adjusted to reflect one-time events.

As part of the merger agreement, Imerys would begin a tender offer for 100% of AMCOL's outstanding shares for $41 per share cash. Imerys anticipates to begin the tender offer within 10 business days of the date of the merger agreement. Following the tender offer closure, Imerys' subsidiary would merge with and into AMCOL, with AMCOL continuing as the surviving corporation, and all AMCOL shares not tendered in the offer would be converted into the right to receive $41 per share cash, without interest. The transaction is not subject to any financing condition and it may close in the first half of 2014.

Goldman, Sachs & Co. is serving as exclusive financial advisor to the Company and Kirkland & Ellis LLP is serving as counsel to the Company in connection with the transaction.

Register
To receive FREE breaking news email alerts for AMCOL International Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.